RecruitingPhase 2NCT06668805
A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
Studying Turner syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- BioMarin Pharmaceutical
- Principal Investigator
- Medical Director, MD, PhDBioMarin Pharmaceutical
- Intervention
- Vosoritide Injection(drug)
- Enrollment
- 54 enrolled
- Eligibility
- 3-11 years · All sexes
- Timeline
- 2024 – 2041
Study locations (24)
- Children's Hospital of Orange County Main Campus - Orange, Orange, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Nemours Children's Hospital, Delaware (Alfred I. Dupont Hospital for Children), Wilmington, Delaware, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Nicklaus Children's Hospital, Miami, Florida, United States
- St. Luke's Children's Endocrinology and Diabetes, Boise, Idaho, United States
- Kentucky Children's Hospital, Lexington, Kentucky, United States
- New York Medical College, Boston, Massachusetts, United States
- M Health Fairview Pediatric Specialty Clinic - Explorer, Minneapolis, Minnesota, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Children's Hospital at Montefiore, The Bronx, New York, United States
- Atrium Health Carolinas Medical Center, Charlotte, North Carolina, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- Children's Medical Center Dallas, Dallas, Texas, United States
- University of Texas Health Science Center at Houston (UT Health), Houston, Texas, United States
- +9 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06668805 on ClinicalTrials.govOther trials for Turner syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07502586Turner Syndrome: Genetic ConsiderationsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- RECRUITINGPHASE3NCT07221851Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient DisordersAscendis Pharma A/S
- RECRUITINGNCT07344012Parental Project Amongst 93 Patients With Turner SyndromeUniversity Hospital, Strasbourg, France
- RECRUITINGPHASE4NCT06834594Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner SyndromeChildren's Mercy Hospital Kansas City
- RECRUITINGNCT06507007Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner SyndromeGødstrup Hospital
- RECRUITINGNCT06794190Characterization of Hepatopathy in Turner Syndrome: Analysis of DeterminantsIRCCS Azienda Ospedaliero-Universitaria di Bologna
- RECRUITINGPHASE2NCT05849389Vosoritide for Short Stature in Turner SyndromeRoopa Kanakatti Shankar, MBBS, MS
- RECRUITINGNANCT06202846Identification of Y Chromosome From Free Circulating DNA in Patients With Turner SyndromeUniversity Hospital, Strasbourg, France